TXMDTherapeuticsMD, Inc.

Nasdaq therapeuticsmd.com


$ 1.88 $ -0.01 (-0.53 %)    

Tuesday, 23-Apr-2024 13:10:42 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.86
$ 1.88
$ 0.00 x 0
$ 0.00 x 0
$ 1.88 - $ 1.88
$ 1.86 - $ 4.73
6,236
na
19.42M
$ 0.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 04-07-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-23-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-04-2021 06-30-2021 10-Q
12 05-06-2021 03-31-2021 10-Q
13 03-04-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-07-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 02-24-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-08-2019 03-31-2019 10-Q
21 02-27-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 07-30-2018 06-30-2018 10-Q
24 05-07-2018 03-31-2018 10-Q
25 02-23-2018 12-31-2017 10-K
26 11-07-2017 09-30-2017 10-Q
27 08-03-2017 06-30-2017 10-Q
28 05-03-2017 03-31-2017 10-Q
29 02-28-2017 12-31-2016 10-K
30 11-04-2016 09-30-2016 10-Q
31 08-05-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-Q
33 02-26-2016 12-31-2015 10-K
34 11-05-2015 09-30-2015 10-Q
35 08-07-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 03-12-2015 12-31-2014 10-K
38 11-07-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-07-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 therapeuticsmd-q3-eps-013-misses-005-estimate

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0....

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

 cantor-fitzgerald-reiterates-neutral-on-therapeuticsmd-maintains-5-price-target

Cantor Fitzgerald analyst Louise Chen reiterates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and maintains $5 price target.

 therapeuticsmd-q2-eps-024-misses-007-estimate-sales-from-cont-ops-40000k-miss-50000k-estimate

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0....

 cigna-is-out-with-a-new-coverage-policy-stating-that-therapeuticsmd-imvexxy-is-now-covered-effective-1124-but-just-disclosed

https://static.cigna.com/assets/chcp/pdf/coveragePolicies/pharmacy/ip_0216_coveragepositioncriteria_vaginal_estrogen_products.pdf

 cantor-fitzgerald-reinstates-neutral-on-therapeuticsmd-announces-5-price-target

Cantor Fitzgerald analyst Louise Chen reinstates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $5 price target.

 therapeuticsmd-q3-sales-2092m-down-from-2541m-yoy

TherapeuticsMD (NASDAQ:TXMD) reported $20.92 million in sales this quarter. This is a 17.67 percent decrease over sales of $25....

 therapeuticsmd-announces-7m-private-placement

TherapeuticsMD, Inc. (NASDAQ:TXMD), ("TherapeuticsMD" or the "Company") an innovative, leading women's heal...

 12-health-care-stocks-moving-in-tuesdays-after-market-session

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The comp...

 therapeuticsmd-appoints-dr-brian-bernick-and-mr-mark-glickman-as-interim-co-chief-executive-officers

TherapeuticsMD, Inc. (NASDAQ:TXMD), ("TherapeuticsMD" or the "Company") an innovative, leading women's heal...

 looking-into-therapeuticsmds-return-on-capital-employed

According to Benzinga Pro, during Q2, TherapeuticsMD (NASDAQ:TXMD) earned $112.28 million, a 329.05% increase from the precedin...

 why-allena-pharmaceuticals-tumbled-over-30-here-are-85-biggest-movers-from-yesterday

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IP...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION